SCHEMBL6540754

SCHEMBL6540754

COC(CN)CC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3692336 0.87 MMP12 (0.47)
Hydrochloric Acid SCHEMBL3698117 0.84 MMP12 (0.46)
SCHEMBL11739232 0.83 CACNA2D1 (0.41)
SCHEMBL16263234 0.81 MMP12 (0.41)
SCHEMBL18331068 0.81 CACNA2D1 (0.52)
SCHEMBL6014532 0.81 MMP12 (0.45)
SCHEMBL25517 0.80
SCHEMBL28068435 0.80 MMP12 (0.43)
SCHEMBL2640092 0.80
SCHEMBL13591194 0.79 LMNA (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090305382-A1 ALKOXY INDOLINONE BASED PROTEIN KINASE INHIBITORS THE SCRIPPS RESEARCH INSTITUTE (US) 2009-12-10 US disclosed
US-7629339-B2 inhibitors of protein kinases and are useful in treating cancer; 4-({5-[5-Fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carbonyl}-amino)-3-methoxy-butyric acid; anticarcinogenic agent THE SCRIPPS RESEARCH INSTITUTE (US) 2009-12-08 US disclosed
US-20090012160-A1 Carnitine Conjugates As Dual Prodrugs, Methods Of Production And Uses Thereof SSV THERAPEUTICS, INC. 2009-01-08 US disclosed
US-6733985-B1 FOR MONITORING EXTRINSIC BLOOD COAGULATION ACTIVITIES; PREPARED FROM RECOMBINANT TISSUE FACTOR AND SYNTHETIC PHOSPHOLIPIDS INTERNATIONAL TECHNIDYNE CORPORATION 2004-05-11 US disclosed
EP-0268343-A2 Enzymatic process for 3-substituted cephalosporins THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (GB) 1988-05-25 EP disclosed